Propranolol Versus Propranolol and Clonidine in Sympathetic Hyperactivity After Moderate Traumatic Brain Injury
Study Details
Study Description
Brief Summary
evaluation of the effect of Propranolol versus propranolol and clonidine on decreasing sympathetic hyperactivity after moderate traumatic brain injury
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Early Phase 1 |
Detailed Description
measuring catecholamine levels after moderate traumatic brain injury after giving propranolol and clonidine
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: propranolol group we will give propranolol 40 milligram tablet twice daily in orogastric or nasogastric tube |
Drug: Propranolol
Test of catecholamines level in moderate traumatic brain injury
Other Names:
|
Active Comparator: propranolol clonidine we will give propranolol 20 milligram tablet twice daily and clonidine 150 microgram tablet twice daily in orogatric or nasogastric tube |
Drug: Propranolol
Test of catecholamines level in moderate traumatic brain injury
Other Names:
|
No Intervention: control group we will give conventional treatment, no propranolol nor clonidine |
Outcome Measures
Primary Outcome Measures
- catecholamine level on day 7 [seven days]
measuring catecholamine level on day 7 after giving study drugs
Secondary Outcome Measures
- mean arterial blood pressure every 4 hours herat rate every 4 hours temperature every 4 hours respiratory rate every 4 hours [7 days]
measuring hemodynamics every 4 hours
- Glascow coma scale [7 days]
measuring glascow coma scale twice daily between 9 and 12 and higher score means better outcome.
Eligibility Criteria
Criteria
Inclusion Criteria:
- GCS on admission between 9 and 12 age 18 up to 60 years both sexes
Exclusion Criteria:
- history of heart disease, cardiac arrhythmia and myocardial infarction diagnosis ofpreexisting brain dysfunction. impending brain herniation and craniotomy diagnosis of spinal cord injuries. diagnisis of severe liver and renal disease current use of beta blocker and or alpha agonist current using of intravenous vasopressor contraindication to enteral feeding and can not swallow pregnancy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Faculty Of Medicine | Minya | Egypt | 61111 |
Sponsors and Collaborators
- Minia University
Investigators
- Study Chair: Amany Khairy, MD, Professor
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 389:1/2020